Nemaura Medical Inc.
NMRD
$0.0002
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -99.48% | -84.72% | -84.72% | 116.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -99.48% | -84.72% | -84.72% | 116.39% |
| Cost of Revenue | 497.70% | 255.44% | 351.21% | 351.21% | 43.45% |
| Gross Profit | -1,084.74% | -1,016.37% | -1,025.06% | -1,025.06% | 1,240.18% |
| SG&A Expenses | -5.10% | -7.95% | -11.94% | -16.77% | 12.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.54% | 12.54% | 7.94% | 1.92% | 14.87% |
| Operating Income | -22.89% | -21.22% | -14.13% | -7.69% | -12.00% |
| Income Before Tax | 20.68% | 32.61% | 13.02% | 0.66% | -5.44% |
| Income Tax Expenses | -- | -- | -- | -- | -4.32% |
| Earnings from Continuing Operations | 18.56% | 31.01% | 10.91% | -1.85% | -5.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.56% | 31.01% | 10.91% | -1.85% | -5.47% |
| EBIT | -22.89% | -21.22% | -14.13% | -7.69% | -12.00% |
| EBITDA | -22.25% | -19.66% | -12.62% | -5.01% | -9.34% |
| EPS Basic | 30.47% | 39.56% | 19.17% | 4.92% | -1.83% |
| Normalized Basic EPS | 38.74% | 46.62% | 26.82% | 13.12% | -1.81% |
| EPS Diluted | 28.93% | 38.21% | 19.17% | 4.92% | -1.83% |
| Normalized Diluted EPS | 38.74% | 46.62% | 26.82% | 13.12% | -1.81% |
| Average Basic Shares Outstanding | 18.51% | 14.46% | 10.35% | 6.39% | 3.72% |
| Average Diluted Shares Outstanding | 18.51% | 14.46% | 10.35% | 6.39% | 3.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |